Editorial: Resecting Assumptions-Do Proctocolectomy Guidelines Hold Up? Author's Reply

Erik Lundqvist^{1

2}, Pär Myrelid^{1

3}, Caroline Nordenvall^{4

5}

Affiliations

¹ Department of Biomedical and Clinical Sciences, Faculty of Health, Linköping University, Linköping, Sweden.
² Department of Surgery, Vrinnevi Hospital, Norrköping, Sweden.
³ Department of Surgery, Linköping University Hospital, Linköping, Sweden.
⁴ Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
⁵ Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden.

Editorial

Erik Lundqvist et al. Aliment Pharmacol Ther. 2025.

. 2025 Aug 22.

doi: 10.1111/apt.70351. Online ahead of print.

Erik Lundqvist^{1

2}, Pär Myrelid^{1

3}, Caroline Nordenvall^{4

5}

¹ Department of Biomedical and Clinical Sciences, Faculty of Health, Linköping University, Linköping, Sweden.
² Department of Surgery, Vrinnevi Hospital, Norrköping, Sweden.
³ Department of Surgery, Linköping University Hospital, Linköping, Sweden.
⁴ Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
⁵ Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden.

No abstract available

References

1. V. Chaudhary and J. Axelrad, “Editorial: Resecting Assumptions—Do Proctocolectomy Guidelines Hold Up?,” Alimentary Pharmacology & Therapeutics (2025): 1–2, https://doi.org/10.1111/apt.70322.
1. E. Lundqvist, K. Westberg, S. E. Boman, et al., “Outcome After Surgery for Colon Cancer in a National Cohort of Patients With and Without Inflammatory Bowel Disease,” Alimentary Pharmacology & Therapeutics (2025): 1–11, https://doi.org/10.1111/apt.70296.
1. C. R. Choi, I. A. Bakir, A. L. Hart, and T. A. Graham, “Clonal Evolution of Colorectal Cancer in IBD,” Nature Reviews Gastroenterology & Hepatology 14, no. 4 (2017): 218–229, https://doi.org/10.1038/nrgastro.2017.1.
1. I. Al Bakir, K. Curtius, G. D. Cresswell, et al., “Low‐Coverage Whole Genome Sequencing of Low‐Grade Dysplasia Strongly Predicts Advanced Neoplasia Risk in Ulcerative Colitis,” Gut 74 (2025): 740–751, https://doi.org/10.1136/gutjnl‐2024‐333353.
1. M. Abdalla, M. Eberhardson, K. Landerholm, R. E. Andersson, and P. Myrelid, “Impact of Inflammatory Bowel Disease and Primary Sclerosing Cholangitis on Colorectal Cancer Risk: National Cohort Study,” Clinical Gastroenterology and Hepatology (2025): S1542‐3565(25)00621‐4, https://doi.org/10.1016/j.cgh.2025.06.037.